N
Intellia Therapeutics, IncNTLA
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. The company's in vivo programs use CRISPR to enable precise editing of disease-causing genes directly inside the human.
US StocksHealthcareSmall CapBiotechnology
Xu hướng giá NTLA
Intellia Therapeutics, Inc · Biểu đồ TradingView đầy đủ
NASDAQ:NTLA